Tirzepatide

Tirzepatide is a medication that belongs to a class of drugs known as GLP-1 receptor agonists, however it also activates GIP which allows it to work more effectively in glycemic control and weight loss. It is used to treat type 2 diabetes by regulating blood sugar levels. Tirzepatide helps to lower blood sugar levels by stimulating insulin secretion, decreasing glucagon secretion, increasing insulin sensitivity, and delaying gastric emptying. This leads to better blood sugar control and reduced risk of complications associated with diabetes. Tirzepatide has been shown to promote weight loss in people with type 2 diabetes. This is because it reduces appetite, slows down the emptying of the stomach, and increases feelings of fullness. Tirzepatide also has been found to reduce the risk of cardiovascular disease, including reducing the risk of heart attacks, strokes, and other cardiovascular events. Tirzepatide is administered once a week by injection, which makes it more convenient than other diabetes medications that need to be taken several times a day.